These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38787409)

  • 1. Elucidating the role of T-Reg related cytokines: serum transforming growth factor beta and interleukin-35 in alopecia areata.
    Yuksek T; Gonul M; Kartal SP; Gungor EB; Hatil SI
    Arch Dermatol Res; 2024 May; 316(6):205. PubMed ID: 38787409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The profile of cytokines (IL-2, IFN-γ, IL-4, IL-10, IL-17A, and IL-23) in active alopecia areata.
    Gautam RK; Singh Y; Gupta A; Arora P; Khurana A; Chitkara A
    J Cosmet Dermatol; 2020 Jan; 19(1):234-240. PubMed ID: 31087753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-helper 17 cytokines (interleukins 17, 21, 22, and 6, and tumor necrosis factor-α) in patients with alopecia areata: association with clinical type and severity.
    Atwa MA; Youssef N; Bayoumy NM
    Int J Dermatol; 2016 Jun; 55(6):666-72. PubMed ID: 26235375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of T helper 17 cells and T regulatory cells in alopecia areata: comparison of lesion and serum cytokine between controls and patients.
    Loh SH; Moon HN; Lew BL; Sim WY
    J Eur Acad Dermatol Venereol; 2018 Jun; 32(6):1028-1033. PubMed ID: 29283462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-helper and regulatory T-cell cytokines in the peripheral blood of patients with active alopecia areata.
    Tembhre MK; Sharma VK
    Br J Dermatol; 2013 Sep; 169(3):543-8. PubMed ID: 23607748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes and significance of Th1/Th2 and Treg/Th17 cells and their cytokines in patients with alopecia areata.
    Yang X; Zhang W; Zhao X; Hou W; Wu Y; Feng D; Meng Z; Zhou X
    Exp Cell Res; 2024 Oct; 442(2):114259. PubMed ID: 39293523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B cell activating factor and T-helper 17 cells: possible synergistic culprits in the pathogenesis of Alopecia Areata.
    Elela MA; Gawdat HI; Hegazy RA; Fawzy MM; Abdel Hay RM; Saadi D; Shaker O
    Arch Dermatol Res; 2016 Mar; 308(2):115-21. PubMed ID: 26796544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo levels of IL-4, IL-10, TGF-beta1 and IFN-gamma mRNA of the peripheral blood mononuclear cells in patients with alopecia areata in comparison to those in patients with atopic dermatitis.
    Katagiri K; Arakawa S; Hatano Y
    Arch Dermatol Res; 2007 Jan; 298(8):397-401. PubMed ID: 17021766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imbalance of T-helper 17 and regulatory T cells in patients with alopecia areata.
    Han YM; Sheng YY; Xu F; Qi SS; Liu XJ; Hu RM; Miao Y; Huang GQ; Yang QP
    J Dermatol; 2015 Oct; 42(10):981-8. PubMed ID: 26077574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between serum IL-17A level and SALT score in patients with alopecia areata before and after NB-UVB therapy.
    Morsy H; Maher R; Negm D
    J Cosmet Dermatol; 2018 Jun; 17(3):533-537. PubMed ID: 29707896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum level of interleukin-17A in patients with alopecia areata and its relationship to age.
    El-Morsy EH; Eid AA; Ghoneim H; Al-Tameemi KA
    Int J Dermatol; 2016 Aug; 55(8):869-74. PubMed ID: 26475394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Serum Th1, Th2, and Th17 Cytokines in Patients with Alopecia Areata: Clinical Implications.
    Waśkiel-Burnat A; Osińska M; Salińska A; Blicharz L; Goldust M; Olszewska M; Rudnicka L
    Cells; 2021 Dec; 10(12):. PubMed ID: 34943905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity.
    Talaat RM; Mohamed SF; Bassyouni IH; Raouf AA
    Cytokine; 2015 Apr; 72(2):146-53. PubMed ID: 25647269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum T helper 1 cytokine levels are greater in patients with alopecia areata regardless of severity or atopy.
    Barahmani N; Lopez A; Babu D; Hernandez M; Donley SE; Duvic M
    Clin Exp Dermatol; 2010 Jun; 35(4):409-16. PubMed ID: 19874320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-sectional study of blood biomarkers of patients with moderate to severe alopecia areata reveals systemic immune and cardiovascular biomarker dysregulation.
    Glickman JW; Dubin C; Renert-Yuval Y; Dahabreh D; Kimmel GW; Auyeung K; Estrada YD; Singer G; Krueger JG; Pavel AB; Guttman-Yassky E
    J Am Acad Dermatol; 2021 Feb; 84(2):370-380. PubMed ID: 32376430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the level of serum Interleukins (IL-2, IL-4, IL-15 andIL-17) and its relationship with disease severity in patients with alopecia areata.
    Aşkın Ö; Yücesoy SN; Coşkun E; Engin B; Serdaroğlu S
    An Bras Dermatol; 2021; 96(5):551-557. PubMed ID: 34281739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SERUM LEVELS OF IL-2 AND IL-17A ARE RELATED TO CLINICAL TYPE AND SEVERITY OF ALOPECIA AREATA.
    Aljabali MA; Kuts L
    Wiad Lek; 2022; 75(1 pt 2):263-267. PubMed ID: 35182133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ex Vivo Treatment with Allogenic Mesenchymal Stem Cells of a Healthy Donor on Peripheral Blood Mononuclear Cells of Patients with Severe Alopecia Areata: Targeting Dysregulated T Cells and the Acquisition of Immunotolerance.
    Kim JE; Lee YJ; Lee KJ; Park SH; Kang H
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36362015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon-gamma in alopecia areata.
    Arca E; Muşabak U; Akar A; Erbil AH; Taştan HB
    Eur J Dermatol; 2004; 14(1):33-6. PubMed ID: 14965793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum cytokine and chemokine profiles in patients with alopecia areata.
    Bilgic O; Sivrikaya A; Unlu A; Altinyazar HC
    J Dermatolog Treat; 2016; 27(3):260-3. PubMed ID: 26367497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.